Late-breaking oral presentation to highlight further evidence supporting potential for deupirfenidone to serve as a new standard of care for the treatment of idiopathic pulmonary fibrosis (IPF) ...

Pulmonary fibrosis is a growing global health concern with varying epidemiological trends. In Western populations, IPF prevalence ranges from 2 to 29 cases per 100,000 individuals, with incidence ...